Watchlist Price Alert

4D pharma (LBPS)

NASDAQ: LBPS · Real-Time Price · USD

1.65

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

4D pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	20.97M	20.75M	8.78M	10.03M	3.84M	12.89M	16.05M	21.41M	11.87M	49.77M	28.66M	1.84M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	10.17M	15.15M	38.13M	10M	40.11M	73.61M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	269K	13.96M	177K	14.37M	188K	14.51M	137K	14.6M	56K	14.63M	23K	13.32M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	305K	291K	212K	198K	288K	290K	262K	253K	194K	238K	n/a
Other Current Assets	13.53M	8.65M	7.66M	10.27M	7.24M	9.18M	6.64M	8.63M	7.55M	6.71M	5.97M	5.43M
Total Current Assets	34.5M	29.71M	16.73M	20.51M	11.27M	22.37M	33.16M	45.45M	57.8M	66.67M	74.98M	80.87M
Property-Plant & Equipment	4.88M	3.98M	4.49M	5.06M	5.16M	5.69M	4.87M	5M	5.21M	4.78M	3.86M	3.96M
Goodwill & Intangibles	19.14M	n/a	14.03M	n/a	13.99M	n/a	14.45M	n/a	14.67M	n/a	14.3M	n/a
Total Long-Term Assets	24.29M	17.94M	18.7M	19.43M	19.34M	20.19M	19.45M	19.6M	19.94M	19.41M	18.18M	17.27M
Total Assets	58.79M	47.65M	35.42M	39.95M	30.61M	42.56M	52.6M	65.05M	77.74M	86.08M	93.16M	98.15M
Account Payables	1.68M	6.96M	3.3M	6.42M	1.22M	3.38M	1.93M	3.25M	1.8M	7.9M	1.16M	2.23M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	108K	74K	73K	73K	68K	n/a	11K	n/a	10K	n/a	n/a	n/a
Other Current Liabilities	4.83M	n/a	3.08M	n/a	4.97M	n/a	3.23M	n/a	3.17M	n/a	3.77M	n/a
Total Current Liabilities	6.62M	7.04M	6.45M	6.5M	6.26M	3.38M	5.18M	3.25M	4.98M	7.9M	4.94M	2.23M
Long-Term Debt	12.7M	936K	986K	1.03M	1.04M	1.1M	15K	21K	26K	n/a	n/a	3.2M
Other Long-Term Liabilities	7.05M	-6.09M	-2.37M	-4.5M	715K	829K	-277K	-121K	1.16M	1.88M	774K	1.6M
Total Long-Term Liabilities	19.76M	948K	999K	1.99M	2.01M	4.21M	1.67M	3.13M	2.97M	2.84M	1.74M	3.83M
Total Liabilities	26.38M	7.98M	7.45M	8.49M	8.27M	7.59M	6.84M	6.38M	7.95M	10.74M	6.67M	6.06M
Total Debt	12.8M	1.01M	1.06M	1.1M	1.11M	1.1M	26K	21K	36K	n/a	n/a	3.2M
Common Stock	646K	451K	329K	274K	164K	164K	164K	164K	164K	162K	162K	162K
Retained Earnings	-180.17M	-168.2M	-112.78M	-100.72M	-87.02M	-75.01M	-63.57M	-50.53M	-39.88M	-31.25M	-19.43M	-14.15M
Comprehensive Income	n/a	n/a	n/a	n/a	-3.25M	n/a	-2.28M	n/a	-1.32M	n/a	-588K	n/a
Shareholders Equity	32.42M	39.66M	27.97M	31.46M	22.34M	34.97M	45.76M	58.67M	69.79M	75.34M	86.48M	92.09M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	10.17M	15.15M	38.13M	10M	40.11M	73.61M